Long-term efficacy of recombinant hepatitis B vaccine and risk of natural infection in infants born to mothers with hepatitis B e antigen

Beasley, 1982, Incidence of hepatitis B virus infections in preschool children in Taiwan, J Infect Dis, 146, 198, 10.1093/infdis/146.2.198 Tsen, 1991, Seroprevalence of hepatitis B virus infection in children in Taipei, 1989: five years after a mass hepatitis B vaccination program, J Med Virol, 34, 96, 10.1002/jmv.1890340205 Stevens, 1975, Vertical transmission of hepatitis B antigen in Taiwan, N Engl J Med, 292, 771, 10.1056/NEJM197504102921503 Chang, 1989, Factors affecting clearance of hepatitis B e antigen in hepatitis B surface antigen carrier children, J P EDIATR, 115, 385 Lee, 1990, Changes of serum hepatitis B virus DNA and aminotransferase levels during the course of chronic hepatitis B virus infection in children, Hepatology, 12, 657, 10.1002/hep.1840120406 Beasley, 1981, Hepatocellular carcinoma and hepatitis B virus: a prospective study of 22707 men in Taiwan, Lancet, 2, 1129, 10.1016/S0140-6736(81)90585-7 Lee, 1991, The protective efficacy of recombinant hepatitis B vaccine in newborn infants of hepatitis B e antigen-positive-hepatitis B surface antigen carrier mothers, Pediatr Infect Dis J, 10, 299, 10.1097/00006454-199104000-00007 Stevens, 1992, Prospects for control of hepatitis B virus infection: implications of childhood vaccination and long-term protection, Pediatrics, 90, 170 Poovorawan, 1992, Long term efficacy of hepatitis B vaccine in infants born to hepatitis B e antigen-positive mothers, Pediatr Infect Dis J, 11, 816, 10.1097/00006454-199210000-00002 Resti, 1991, Five-year follow-up of vaccination against hepatitis B virus in newborns vaccinated with a reduced number of doses, Vaccine, 9, 15, 10.1016/0264-410X(91)90310-3 Gonzalez, 1993, A 7-year follow-up of newborns vaccinated against hepatitis B, Vaccine, 11, 1033, 10.1016/0264-410X(93)90129-L Ding, 1993, A 9-year follow-up study of the immunogenicity and long-term efficacy of plasma-derived hepatitis B vaccine in high-risk Chinese neonates, Clin Infect Dis, 17, 475, 10.1093/clinids/17.3.475 Lai, 1993, Five-year follow-up of a prospective randomized trial of hepatitis B recombinant DNA yeast vaccine vs. plasma-derived vaccine in children: immunogenicity and anamnestic responses, Hepatology, 18, 763, 10.1002/hep.1840180403 Greenberg, 1993, Pediatric experience with recombinant hepatitis B vaccines and relevant safety and immunogenicity studies, Pediatr Infect Dis J, 12, 438, 10.1097/00006454-199305000-00037 Coursaget, 1991, Scheduling of revaccination against hepatitis B virus, Lancet, 337, 1180, 10.1016/0140-6736(91)92857-X Moyes, 1990, Very low dose hepatitis B vaccination in the newborn: anamnestic response to booster at four years, J Med Virol, 30, 216, 10.1002/jmv.1890300314 Yvonnet, 1987, Hepatitis B vaccine in infants from an endemic area: long-term anti-HBs persistence and revaccination, J Med Virol, 22, 315, 10.1002/jmv.1890220404 Coursaget, 1986, Seven-year study of hepatitis B vaccine efficacy in infants from an endemic area (Senegal), Lancet, 2, 1143, 10.1016/S0140-6736(86)90543-X Whittle, 1991, Vaccination against hepatitis B and protection against chronic viral carriage in the Gambia, Lancet, 337, 747, 10.1016/0140-6736(91)91367-4 Hadler, 1986, Long-term immunogenicity and efficacy of hepatitis B vaccine in homosexual men, N Engl J Med, 315, 209, 10.1056/NEJM198607243150401 Delage, 1993, Combined active- passive immunization against the hepatitis B virus: five-year follow-up of children born to hepatitis B surface antigen-positive mothers, Pediatr Infect Dis J, 12, 126, 10.1097/00006454-199302000-00004 Jilg, 1988, Persistence of specific antibodies after hepatitis B vaccination, J Hepatol, 6, 201, 10.1016/S0168-8278(88)80032-1 Hsu, 1990, Studies on the efficacy of a mass immunization program against hepatitis B in Taiwan: a three-year follow-up, 509 Hwang, 1991, Five-year follow-up of HBV vaccination with plasma-derived vaccine in neonates: evaluation of immunogenicity and efficacy against perinatal transmission, 759 Beasley, 1983, Prevention of perinatally transmitted hepatitis B virus infection with hepatitis B immune globulin and hepatitis B vaccine, Lancet, 2, 1099, 10.1016/S0140-6736(83)90624-4 Goh, 1992, Comparison of the immune response of four different dosages of a yeast-recombinant hepatitis B vaccine in Singapore children: a four- year follow-up study, Bull WHO, 70, 233 Heijtink, 1988, Hepatitis B vaccination in newborn babies [Letter], Lancet, 1, 1226, 10.1016/S0140-6736(88)92045-4 Chang, 1989, Maternal transmission of hepatitis B virus in childhood hepatocellular carcinoma, Cancer, 64, 2377, 10.1002/1097-0142(19891201)64:11<2377::AID-CNCR2820641130>3.0.CO;2-8 Hou, 1993, Heterosexual transmission as the most common route of acute hepatitis B virus infection among adults in Taiwan: the importance of extending vaccination to susceptible adults, J Infect Dis, 167, 938, 10.1093/infdis/167.4.938